 | • レポートコード：MRC2-11QY09139 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はリスペリドンのグローバル市場について調査・分析したレポートです。種類別（経口、注射可能型）市場規模、用途別（統合失調症、双極性障害）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別リスペリドンの競争状況、市場シェア ・世界のリスペリドン市場：種類別市場規模 2015年-2020年（経口、注射可能型） ・世界のリスペリドン市場：種類別市場規模予測 2021年-2026年（経口、注射可能型） ・世界のリスペリドン市場：用途別市場規模 2015年-2020年（統合失調症、双極性障害） ・世界のリスペリドン市場：用途別市場規模予測 2021年-2026年（統合失調症、双極性障害） ・北米のリスペリドン市場分析：米国、カナダ ・ヨーロッパのリスペリドン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのリスペリドン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のリスペリドン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのリスペリドン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Janssen Pharmaceutica、Teva、Sun Pharmaceutical、Aurobindo、Cipla、Invent Farma Group、Medichem、Interquim、IPCA、RPG、Sharon、Torrent Pharmaceuticals、Temad、Wuxi Jida、Changzhou Siyao Pharmaceuticals、Ningbo Team Pharm、Zhejiang Huahai Pharmaceutical、TIPR、Qilu Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Risperidone Market
The global Risperidone market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Risperidone Scope and Market Size
Risperidone market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Risperidone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Risperidone market is segmented into
Oral
Injectable
Segment by Application, the Risperidone market is segmented into
Schizophrenia
Bipolar Disorder
Regional and Country-level Analysis
The Risperidone market is analysed and market size information is provided by regions (countries).
The key regions covered in the Risperidone market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Risperidone Market Share Analysis
Risperidone market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Risperidone business, the date to enter into the Risperidone market, Risperidone product introduction, recent developments, etc.
The major vendors covered:
Janssen Pharmaceutica
Teva
Sun Pharmaceutical
Aurobindo
Cipla
Invent Farma Group
Medichem
Interquim
IPCA
RPG
Sharon
Torrent Pharmaceuticals
Temad
Wuxi Jida
Changzhou Siyao Pharmaceuticals
Ningbo Team Pharm
Zhejiang Huahai Pharmaceutical
TIPR
Qilu Pharmaceutical
1 Study Coverage
1.1 Risperidone Product Introduction
1.2 Market Segments
1.3 Key Risperidone Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Risperidone Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injectable
1.5 Market by Application
1.5.1 Global Risperidone Market Size Growth Rate by Application
1.5.2 Schizophrenia
1.5.3 Bipolar Disorder
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Risperidone Market Size, Estimates and Forecasts
2.1.1 Global Risperidone Revenue 2015-2026
2.1.2 Global Risperidone Sales 2015-2026
2.2 Global Risperidone, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Risperidone Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Risperidone Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Risperidone Competitor Landscape by Players
3.1 Risperidone Sales by Manufacturers
3.1.1 Risperidone Sales by Manufacturers (2015-2020)
3.1.2 Risperidone Sales Market Share by Manufacturers (2015-2020)
3.2 Risperidone Revenue by Manufacturers
3.2.1 Risperidone Revenue by Manufacturers (2015-2020)
3.2.2 Risperidone Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Risperidone Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Risperidone Revenue in 2019
3.2.5 Global Risperidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Risperidone Price by Manufacturers
3.4 Risperidone Manufacturing Base Distribution, Product Types
3.4.1 Risperidone Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Risperidone Product Type
3.4.3 Date of International Manufacturers Enter into Risperidone Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Risperidone Market Size by Type (2015-2020)
4.1.1 Global Risperidone Sales by Type (2015-2020)
4.1.2 Global Risperidone Revenue by Type (2015-2020)
4.1.3 Risperidone Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Risperidone Market Size Forecast by Type (2021-2026)
4.2.1 Global Risperidone Sales Forecast by Type (2021-2026)
4.2.2 Global Risperidone Revenue Forecast by Type (2021-2026)
4.2.3 Risperidone Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Risperidone Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Risperidone Market Size by Application (2015-2020)
5.1.1 Global Risperidone Sales by Application (2015-2020)
5.1.2 Global Risperidone Revenue by Application (2015-2020)
5.1.3 Risperidone Price by Application (2015-2020)
5.2 Risperidone Market Size Forecast by Application (2021-2026)
5.2.1 Global Risperidone Sales Forecast by Application (2021-2026)
5.2.2 Global Risperidone Revenue Forecast by Application (2021-2026)
5.2.3 Global Risperidone Price Forecast by Application (2021-2026)
6 North America
6.1 North America Risperidone by Country
6.1.1 North America Risperidone Sales by Country
6.1.2 North America Risperidone Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Risperidone Market Facts & Figures by Type
6.3 North America Risperidone Market Facts & Figures by Application
7 Europe
7.1 Europe Risperidone by Country
7.1.1 Europe Risperidone Sales by Country
7.1.2 Europe Risperidone Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Risperidone Market Facts & Figures by Type
7.3 Europe Risperidone Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Risperidone by Region
8.1.1 Asia Pacific Risperidone Sales by Region
8.1.2 Asia Pacific Risperidone Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Risperidone Market Facts & Figures by Type
8.3 Asia Pacific Risperidone Market Facts & Figures by Application
9 Latin America
9.1 Latin America Risperidone by Country
9.1.1 Latin America Risperidone Sales by Country
9.1.2 Latin America Risperidone Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Risperidone Market Facts & Figures by Type
9.3 Central & South America Risperidone Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Risperidone by Country
10.1.1 Middle East and Africa Risperidone Sales by Country
10.1.2 Middle East and Africa Risperidone Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Risperidone Market Facts & Figures by Type
10.3 Middle East and Africa Risperidone Market Facts & Figures by Application
11 Company Profiles
11.1 Janssen Pharmaceutica
11.1.1 Janssen Pharmaceutica Corporation Information
11.1.2 Janssen Pharmaceutica Description and Business Overview
11.1.3 Janssen Pharmaceutica Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Janssen Pharmaceutica Risperidone Products Offered
11.1.5 Janssen Pharmaceutica Related Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Description and Business Overview
11.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Teva Risperidone Products Offered
11.2.5 Teva Related Developments
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Corporation Information
11.3.2 Sun Pharmaceutical Description and Business Overview
11.3.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sun Pharmaceutical Risperidone Products Offered
11.3.5 Sun Pharmaceutical Related Developments
11.4 Aurobindo
11.4.1 Aurobindo Corporation Information
11.4.2 Aurobindo Description and Business Overview
11.4.3 Aurobindo Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Aurobindo Risperidone Products Offered
11.4.5 Aurobindo Related Developments
11.5 Cipla
11.5.1 Cipla Corporation Information
11.5.2 Cipla Description and Business Overview
11.5.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Cipla Risperidone Products Offered
11.5.5 Cipla Related Developments
11.6 Invent Farma Group
11.6.1 Invent Farma Group Corporation Information
11.6.2 Invent Farma Group Description and Business Overview
11.6.3 Invent Farma Group Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Invent Farma Group Risperidone Products Offered
11.6.5 Invent Farma Group Related Developments
11.7 Medichem
11.7.1 Medichem Corporation Information
11.7.2 Medichem Description and Business Overview
11.7.3 Medichem Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Medichem Risperidone Products Offered
11.7.5 Medichem Related Developments
11.8 Interquim
11.8.1 Interquim Corporation Information
11.8.2 Interquim Description and Business Overview
11.8.3 Interquim Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Interquim Risperidone Products Offered
11.8.5 Interquim Related Developments
11.9 IPCA
11.9.1 IPCA Corporation Information
11.9.2 IPCA Description and Business Overview
11.9.3 IPCA Sales, Revenue and Gross Margin (2015-2020)
11.9.4 IPCA Risperidone Products Offered
11.9.5 IPCA Related Developments
11.10 RPG
11.10.1 RPG Corporation Information
11.10.2 RPG Description and Business Overview
11.10.3 RPG Sales, Revenue and Gross Margin (2015-2020)
11.10.4 RPG Risperidone Products Offered
11.10.5 RPG Related Developments
11.1 Janssen Pharmaceutica
11.1.1 Janssen Pharmaceutica Corporation Information
11.1.2 Janssen Pharmaceutica Description and Business Overview
11.1.3 Janssen Pharmaceutica Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Janssen Pharmaceutica Risperidone Products Offered
11.1.5 Janssen Pharmaceutica Related Developments
11.12 Torrent Pharmaceuticals
11.12.1 Torrent Pharmaceuticals Corporation Information
11.12.2 Torrent Pharmaceuticals Description and Business Overview
11.12.3 Torrent Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Torrent Pharmaceuticals Products Offered
11.12.5 Torrent Pharmaceuticals Related Developments
11.13 Temad
11.13.1 Temad Corporation Information
11.13.2 Temad Description and Business Overview
11.13.3 Temad Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Temad Products Offered
11.13.5 Temad Related Developments
11.14 Wuxi Jida
11.14.1 Wuxi Jida Corporation Information
11.14.2 Wuxi Jida Description and Business Overview
11.14.3 Wuxi Jida Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Wuxi Jida Products Offered
11.14.5 Wuxi Jida Related Developments
11.15 Changzhou Siyao Pharmaceuticals
11.15.1 Changzhou Siyao Pharmaceuticals Corporation Information
11.15.2 Changzhou Siyao Pharmaceuticals Description and Business Overview
11.15.3 Changzhou Siyao Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Changzhou Siyao Pharmaceuticals Products Offered
11.15.5 Changzhou Siyao Pharmaceuticals Related Developments
11.16 Ningbo Team Pharm
11.16.1 Ningbo Team Pharm Corporation Information
11.16.2 Ningbo Team Pharm Description and Business Overview
11.16.3 Ningbo Team Pharm Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Ningbo Team Pharm Products Offered
11.16.5 Ningbo Team Pharm Related Developments
11.17 Zhejiang Huahai Pharmaceutical
11.17.1 Zhejiang Huahai Pharmaceutical Corporation Information
11.17.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
11.17.3 Zhejiang Huahai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Zhejiang Huahai Pharmaceutical Products Offered
11.17.5 Zhejiang Huahai Pharmaceutical Related Developments
11.18 TIPR
11.18.1 TIPR Corporation Information
11.18.2 TIPR Description and Business Overview
11.18.3 TIPR Sales, Revenue and Gross Margin (2015-2020)
11.18.4 TIPR Products Offered
11.18.5 TIPR Related Developments
11.19 Qilu Pharmaceutical
11.19.1 Qilu Pharmaceutical Corporation Information
11.19.2 Qilu Pharmaceutical Description and Business Overview
11.19.3 Qilu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Qilu Pharmaceutical Products Offered
11.19.5 Qilu Pharmaceutical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Risperidone Market Estimates and Projections by Region
12.1.1 Global Risperidone Sales Forecast by Regions 2021-2026
12.1.2 Global Risperidone Revenue Forecast by Regions 2021-2026
12.2 North America Risperidone Market Size Forecast (2021-2026)
12.2.1 North America: Risperidone Sales Forecast (2021-2026)
12.2.2 North America: Risperidone Revenue Forecast (2021-2026)
12.2.3 North America: Risperidone Market Size Forecast by Country (2021-2026)
12.3 Europe Risperidone Market Size Forecast (2021-2026)
12.3.1 Europe: Risperidone Sales Forecast (2021-2026)
12.3.2 Europe: Risperidone Revenue Forecast (2021-2026)
12.3.3 Europe: Risperidone Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Risperidone Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Risperidone Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Risperidone Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Risperidone Market Size Forecast by Region (2021-2026)
12.5 Latin America Risperidone Market Size Forecast (2021-2026)
12.5.1 Latin America: Risperidone Sales Forecast (2021-2026)
12.5.2 Latin America: Risperidone Revenue Forecast (2021-2026)
12.5.3 Latin America: Risperidone Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Risperidone Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Risperidone Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Risperidone Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Risperidone Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Risperidone Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Risperidone Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Risperidone Market Segments
Table 2. Ranking of Global Top Risperidone Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Risperidone Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injectable
Table 6. Global Risperidone Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 7. Global Risperidone Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 8. Global Risperidone Sales by Regions 2015-2020 (K Pcs)
Table 9. Global Risperidone Sales Market Share by Regions (2015-2020)
Table 10. Global Risperidone Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Risperidone Sales by Manufacturers (2015-2020) (K Pcs)
Table 12. Global Risperidone Sales Share by Manufacturers (2015-2020)
Table 13. Global Risperidone Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Risperidone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Risperidone as of 2019)
Table 15. Risperidone Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Risperidone Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Risperidone Price (2015-2020) (USD/Pcs)
Table 18. Risperidone Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Risperidone Product Type
Table 20. Date of International Manufacturers Enter into Risperidone Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Risperidone Sales by Type (2015-2020) (K Pcs)
Table 23. Global Risperidone Sales Share by Type (2015-2020)
Table 24. Global Risperidone Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Risperidone Revenue Share by Type (2015-2020)
Table 26. Risperidone Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 27. Global Risperidone Sales by Application (2015-2020) (K Pcs)
Table 28. Global Risperidone Sales Share by Application (2015-2020)
Table 29. North America Risperidone Sales by Country (2015-2020) (K Pcs)
Table 30. North America Risperidone Sales Market Share by Country (2015-2020)
Table 31. North America Risperidone Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Risperidone Revenue Market Share by Country (2015-2020)
Table 33. North America Risperidone Sales by Type (2015-2020) (K Pcs)
Table 34. North America Risperidone Sales Market Share by Type (2015-2020)
Table 35. North America Risperidone Sales by Application (2015-2020) (K Pcs)
Table 36. North America Risperidone Sales Market Share by Application (2015-2020)
Table 37. Europe Risperidone Sales by Country (2015-2020) (K Pcs)
Table 38. Europe Risperidone Sales Market Share by Country (2015-2020)
Table 39. Europe Risperidone Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Risperidone Revenue Market Share by Country (2015-2020)
Table 41. Europe Risperidone Sales by Type (2015-2020) (K Pcs)
Table 42. Europe Risperidone Sales Market Share by Type (2015-2020)
Table 43. Europe Risperidone Sales by Application (2015-2020) (K Pcs)
Table 44. Europe Risperidone Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Risperidone Sales by Region (2015-2020) (K Pcs)
Table 46. Asia Pacific Risperidone Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Risperidone Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Risperidone Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Risperidone Sales by Type (2015-2020) (K Pcs)
Table 50. Asia Pacific Risperidone Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Risperidone Sales by Application (2015-2020) (K Pcs)
Table 52. Asia Pacific Risperidone Sales Market Share by Application (2015-2020)
Table 53. Latin America Risperidone Sales by Country (2015-2020) (K Pcs)
Table 54. Latin America Risperidone Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Risperidone Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Risperidone Revenue Market Share by Country (2015-2020)
Table 57. Latin America Risperidone Sales by Type (2015-2020) (K Pcs)
Table 58. Latin America Risperidone Sales Market Share by Type (2015-2020)
Table 59. Latin America Risperidone Sales by Application (2015-2020) (K Pcs)
Table 60. Latin America Risperidone Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Risperidone Sales by Country (2015-2020) (K Pcs)
Table 62. Middle East and Africa Risperidone Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Risperidone Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Risperidone Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Risperidone Sales by Type (2015-2020) (K Pcs)
Table 66. Middle East and Africa Risperidone Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Risperidone Sales by Application (2015-2020) (K Pcs)
Table 68. Middle East and Africa Risperidone Sales Market Share by Application (2015-2020)
Table 69. Janssen Pharmaceutica Corporation Information
Table 70. Janssen Pharmaceutica Description and Major Businesses
Table 71. Janssen Pharmaceutica Risperidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 72. Janssen Pharmaceutica Product
Table 73. Janssen Pharmaceutica Recent Development
Table 74. Teva Corporation Information
Table 75. Teva Description and Major Businesses
Table 76. Teva Risperidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Teva Product
Table 78. Teva Recent Development
Table 79. Sun Pharmaceutical Corporation Information
Table 80. Sun Pharmaceutical Description and Major Businesses
Table 81. Sun Pharmaceutical Risperidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Sun Pharmaceutical Product
Table 83. Sun Pharmaceutical Recent Development
Table 84. Aurobindo Corporation Information
Table 85. Aurobindo Description and Major Businesses
Table 86. Aurobindo Risperidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Aurobindo Product
Table 88. Aurobindo Recent Development
Table 89. Cipla Corporation Information
Table 90. Cipla Description and Major Businesses
Table 91. Cipla Risperidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Cipla Product
Table 93. Cipla Recent Development
Table 94. Invent Farma Group Corporation Information
Table 95. Invent Farma Group Description and Major Businesses
Table 96. Invent Farma Group Risperidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Invent Farma Group Product
Table 98. Invent Farma Group Recent Development
Table 99. Medichem Corporation Information
Table 100. Medichem Description and Major Businesses
Table 101. Medichem Risperidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Medichem Product
Table 103. Medichem Recent Development
Table 104. Interquim Corporation Information
Table 105. Interquim Description and Major Businesses
Table 106. Interquim Risperidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Interquim Product
Table 108. Interquim Recent Development
Table 109. IPCA Corporation Information
Table 110. IPCA Description and Major Businesses
Table 111. IPCA Risperidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. IPCA Product
Table 113. IPCA Recent Development
Table 114. RPG Corporation Information
Table 115. RPG Description and Major Businesses
Table 116. RPG Risperidone Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. RPG Product
Table 118. RPG Recent Development
Table 119. Sharon Corporation Information
Table 120. Sharon Description and Major Businesses
Table 121. Sharon Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Sharon Product
Table 123. Sharon Recent Development
Table 124. Torrent Pharmaceuticals Corporation Information
Table 125. Torrent Pharmaceuticals Description and Major Businesses
Table 126. Torrent Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Torrent Pharmaceuticals Product
Table 128. Torrent Pharmaceuticals Recent Development
Table 129. Temad Corporation Information
Table 130. Temad Description and Major Businesses
Table 131. Temad Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Temad Product
Table 133. Temad Recent Development
Table 134. Wuxi Jida Corporation Information
Table 135. Wuxi Jida Description and Major Businesses
Table 136. Wuxi Jida Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Wuxi Jida Product
Table 138. Wuxi Jida Recent Development
Table 139. Changzhou Siyao Pharmaceuticals Corporation Information
Table 140. Changzhou Siyao Pharmaceuticals Description and Major Businesses
Table 141. Changzhou Siyao Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 142. Changzhou Siyao Pharmaceuticals Product
Table 143. Changzhou Siyao Pharmaceuticals Recent Development
Table 144. Ningbo Team Pharm Corporation Information
Table 145. Ningbo Team Pharm Description and Major Businesses
Table 146. Ningbo Team Pharm Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 147. Ningbo Team Pharm Product
Table 148. Ningbo Team Pharm Recent Development
Table 149. Zhejiang Huahai Pharmaceutical Corporation Information
Table 150. Zhejiang Huahai Pharmaceutical Description and Major Businesses
Table 151. Zhejiang Huahai Pharmaceutical Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 152. Zhejiang Huahai Pharmaceutical Product
Table 153. Zhejiang Huahai Pharmaceutical Recent Development
Table 154. TIPR Corporation Information
Table 155. TIPR Description and Major Businesses
Table 156. TIPR Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 157. TIPR Product
Table 158. TIPR Recent Development
Table 159. Qilu Pharmaceutical Corporation Information
Table 160. Qilu Pharmaceutical Description and Major Businesses
Table 161. Qilu Pharmaceutical Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 162. Qilu Pharmaceutical Product
Table 163. Qilu Pharmaceutical Recent Development
Table 164. Global Risperidone Sales Forecast by Regions (2021-2026) (K Pcs)
Table 165. Global Risperidone Sales Market Share Forecast by Regions (2021-2026)
Table 166. Global Risperidone Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 167. Global Risperidone Revenue Market Share Forecast by Regions (2021-2026)
Table 168. North America: Risperidone Sales Forecast by Country (2021-2026) (K Pcs)
Table 169. North America: Risperidone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Europe: Risperidone Sales Forecast by Country (2021-2026) (K Pcs)
Table 171. Europe: Risperidone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Asia Pacific: Risperidone Sales Forecast by Region (2021-2026) (K Pcs)
Table 173. Asia Pacific: Risperidone Revenue Forecast by Region (2021-2026) (US$ Million)
Table 174. Latin America: Risperidone Sales Forecast by Country (2021-2026) (K Pcs)
Table 175. Latin America: Risperidone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 176. Middle East and Africa: Risperidone Sales Forecast by Country (2021-2026) (K Pcs)
Table 177. Middle East and Africa: Risperidone Revenue Forecast by Country (2021-2026) (US$ Million)
Table 178. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 179. Key Challenges
Table 180. Market Risks
Table 181. Main Points Interviewed from Key Risperidone Players
Table 182. Risperidone Customers List
Table 183. Risperidone Distributors List
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Risperidone Product Picture
Figure 2. Global Risperidone Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injectable Product Picture
Figure 5. Global Risperidone Sales Market Share by Application in 2020 & 2026
Figure 6. Schizophrenia
Figure 7. Bipolar Disorder
Figure 8. Risperidone Report Years Considered
Figure 9. Global Risperidone Market Size 2015-2026 (US$ Million)
Figure 10. Global Risperidone Sales 2015-2026 (K Pcs)
Figure 11. Global Risperidone Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Risperidone Sales Market Share by Region (2015-2020)
Figure 13. Global Risperidone Sales Market Share by Region in 2019
Figure 14. Global Risperidone Revenue Market Share by Region (2015-2020)
Figure 15. Global Risperidone Revenue Market Share by Region in 2019
Figure 16. Global Risperidone Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Risperidone Revenue in 2019
Figure 18. Risperidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Risperidone Sales Market Share by Type (2015-2020)
Figure 20. Global Risperidone Sales Market Share by Type in 2019
Figure 21. Global Risperidone Revenue Market Share by Type (2015-2020)
Figure 22. Global Risperidone Revenue Market Share by Type in 2019
Figure 23. Global Risperidone Market Share by Price Range (2015-2020)
Figure 24. Global Risperidone Sales Market Share by Application (2015-2020)
Figure 25. Global Risperidone Sales Market Share by Application in 2019
Figure 26. Global Risperidone Revenue Market Share by Application (2015-2020)
Figure 27. Global Risperidone Revenue Market Share by Application in 2019
Figure 28. North America Risperidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 29. North America Risperidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Risperidone Sales Market Share by Country in 2019
Figure 31. North America Risperidone Revenue Market Share by Country in 2019
Figure 32. U.S. Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 33. U.S. Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. Canada Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Risperidone Market Share by Type in 2019
Figure 37. North America Risperidone Market Share by Application in 2019
Figure 38. Europe Risperidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 39. Europe Risperidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Risperidone Sales Market Share by Country in 2019
Figure 41. Europe Risperidone Revenue Market Share by Country in 2019
Figure 42. Germany Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. Germany Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. France Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. U.K. Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Italy Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Russia Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Risperidone Market Share by Type in 2019
Figure 53. Europe Risperidone Market Share by Application in 2019
Figure 54. Asia Pacific Risperidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 55. Asia Pacific Risperidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Risperidone Sales Market Share by Region in 2019
Figure 57. Asia Pacific Risperidone Revenue Market Share by Region in 2019
Figure 58. China Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. China Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Japan Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. South Korea Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. India Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Australia Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Taiwan Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Indonesia Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Thailand Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Malaysia Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Philippines Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Vietnam Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Risperidone Market Share by Type in 2019
Figure 81. Asia Pacific Risperidone Market Share by Application in 2019
Figure 82. Latin America Risperidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 83. Latin America Risperidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Risperidone Sales Market Share by Country in 2019
Figure 85. Latin America Risperidone Revenue Market Share by Country in 2019
Figure 86. Mexico Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Mexico Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Brazil Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Argentina Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Risperidone Market Share by Type in 2019
Figure 93. Latin America Risperidone Market Share by Application in 2019
Figure 94. Middle East and Africa Risperidone Sales Growth Rate 2015-2020 (K Pcs)
Figure 95. Middle East and Africa Risperidone Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Risperidone Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Risperidone Revenue Market Share by Country in 2019
Figure 98. Turkey Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Turkey Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Saudi Arabia Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Risperidone Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. U.A.E Risperidone Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Risperidone Market Share by Type in 2019
Figure 105. Middle East and Africa Risperidone Market Share by Application in 2019
Figure 106. North America Risperidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 107. North America Risperidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Risperidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 109. Europe Risperidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Risperidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. Asia Pacific Risperidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Risperidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Latin America Risperidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Risperidone Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Middle East and Africa Risperidone Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
双極性障害治療の世界市場（～2026年） Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. Accord…- 統合失調症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Schizophrenia Drugs Market The global Schizophrenia Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Schizophrenia Drugs Scope and Market Size Schizophrenia Drugs market is seg…
- 統合失調症治療の世界市場（～2026年） Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schizophrenia. Market Analysis and Insights: Global Schizophr…
- 長時間作用型注射剤（LAI）の世界市場（～2026年） Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdo…
- 燃料電池バイポーラ板の世界市場（～2026年） Market Analysis and Insights: Global Fuel Cell Bipolar Plates Market The global Fuel Cell Bipolar Plates market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Fuel Cell Bipolar Plates Scope and Market Size Fuel Cell Bipolar …